1 Vote
1 Contributor
158 Views
0 Saved
You might also be interested in
First of all, breast cancer isn't a death sentence: overall, about 60% of women survive breast cancer, and go on to live long and healthy lives. The percentage can be as high as 99%, depending on the particular type and stage of breast cancer. Stage 1, 2, 3 is easily curable by surgery followed b....
Good news! The short answer is a resounding no. Cow milk’s relationship with breast cancer has been studied extensively over the past 25 years, and while the details of the studies don’t always agree, most of the studies agree on the basics: that dairy is not associated with an increased risk for br....
Generally, women having their routine mammogram will receive a letter within one month with normal results. But if the doctor finds something suspicious, they’ll call you back, mostly within just 5 days, to take fresh pictures or other tests. Yes, that call may seem to be scary, but a suspicious fin....
Receive guidance from the first consultation through the entire hospitalization process.
Medical experts assist the patients to find the right doctor and book appointments.
Consult with 5000+ doctors online and get all your health queries answered.
Deepak Kumar
It depends on the country. Overdiagnosis relates to the finding of a cancer that doesn’t act in a life-limiting way. Since the beginning of mammography and PSA eras we have diagnosed a lot of such disease.Mammography has not changed the percentage of women who have metastatic disease, rather it has increased the diagnosis of breast cancer enormously with many, many of these not a threat to life.With respect to PSA screening it’s not clear at all whether it saves lives, either. But such screening increases the number of patients diagnosed and treated for non-disease.But the problem is that up to now we haven’t been able to distinguish disease from non-disease very well so we treat people to be sure. But we’re entering into the era of personalised medicine.
Recently an excellent paper was published showing the size of a breast tumour does not signal malignant behaviour nearly as much as its genetic makeup.